Sana Biotechnology, Inc. (SANA)
3.78
-0.13
(-3.32%)
USD |
NASDAQ |
Aug 24, 16:00
3.785
0.00 (0.00%)
After-Hours: 20:00
Sana Biotechnology Enterprise Value : 1.040B for Aug. 24, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 24, 2026 | 1.040B |
| August 21, 2026 | 1.079B |
| August 20, 2026 | 1.028B |
| August 19, 2026 | 1.136B |
| August 18, 2026 | 995.53M |
| August 17, 2026 | 1.011B |
| August 14, 2026 | 971.59M |
| August 13, 2026 | 1.008B |
| August 12, 2026 | 1.037B |
| August 11, 2026 | 1.043B |
| August 10, 2026 | 989.55M |
| August 07, 2026 | 962.61M |
| August 06, 2026 | 929.69M |
| August 05, 2026 | 959.62M |
| August 04, 2026 | 926.69M |
| August 03, 2026 | 860.85M |
| July 31, 2026 | 845.88M |
| July 30, 2026 | 881.80M |
| July 29, 2026 | 857.85M |
| July 28, 2026 | 893.77M |
| July 27, 2026 | 890.78M |
| July 24, 2026 | 860.85M |
| July 23, 2026 | 869.83M |
| July 22, 2026 | 842.89M |
| July 21, 2026 | 854.86M |
| Date | Value |
|---|---|
| July 20, 2026 | 848.87M |
| July 17, 2026 | 851.87M |
| July 16, 2026 | 857.85M |
| July 15, 2026 | 971.59M |
| July 14, 2026 | 977.58M |
| July 13, 2026 | 998.53M |
| July 10, 2026 | 1.061B |
| July 09, 2026 | 1.085B |
| July 08, 2026 | 1.100B |
| July 07, 2026 | 1.142B |
| July 06, 2026 | 1.097B |
| July 02, 2026 | 1.109B |
| July 01, 2026 | 974.58M |
| June 30, 2026 | 953.63M |
| June 29, 2026 | 900.87M |
| June 26, 2026 | 892.77M |
| June 25, 2026 | 849.60M |
| June 24, 2026 | 855.00M |
| June 23, 2026 | 873.88M |
| June 22, 2026 | 876.58M |
| June 18, 2026 | 819.92M |
| June 17, 2026 | 790.24M |
| June 16, 2026 | 733.58M |
| June 15, 2026 | 738.98M |
| June 12, 2026 | 693.11M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Twist Bioscience Corp. | 8.751B |
| Beam Therapeutics, Inc. | 2.020B |
| Prime Medicine, Inc. | 604.80M |
| Intellia Therapeutics, Inc. | 1.394B |
| Moderna, Inc. | 51.57B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -63.64M |
| Total Expenses (Quarterly) | 63.64M |
| EPS Diluted (Quarterly) | -0.2152 |
| Earnings Yield | -20.12% |
| Normalized Earnings Yield | -17.95 |